Australia markets close in 4 hours 40 minutes

GlaxoSmithKline plc (GSK)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
34.91+0.63 (+1.84%)
At close: 4:00PM EST
Currency in USD

Valuation measures

Market cap (intra-day) 586.88B
Enterprise value 386.94B
Trailing P/E 35.19
Forward P/E 111.08
PEG ratio (5-yr expected) 12.80
Price/sales (ttm)N/A
Price/book (mrq)14.51
Enterprise value/revenue 3N/A
Enterprise value/EBITDA 6N/A

Trading information

Stock price history

Beta (5Y monthly) 0.35
52-week change 3-14.27%
S&P500 52-week change 339.88%
52-week high 343.18
52-week low 331.43
50-day moving average 335.96
200-day moving average 337.16

Share statistics

Avg vol (3-month) 35.63M
Avg vol (10-day) 36.48M
Shares outstanding 52.52B
Float 2.45B
% held by insiders 10.01%
% held by institutions 111.88%
Shares short (11 Feb 2021) 419.41M
Short ratio (11 Feb 2021) 42.94
Short % of float (11 Feb 2021) 4N/A
Short % of shares outstanding (11 Feb 2021) 40.77%
Shares short (prior month 14 Jan 2021) 413.73M

Dividends & splits

Forward annual dividend rate 42.11
Forward annual dividend yield 46.04%
Trailing annual dividend rate 31.06
Trailing annual dividend yield 33.09%
5-year average dividend yield 45.21
Payout ratio 469.30%
Dividend date 307 Apr 2021
Ex-dividend date 417 Feb 2021
Last split factor 22:1
Last split date 311 Nov 1991

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Dec 2020

Profitability

Profit margin 16.86%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)6.29%
Return on equity (ttm)32.62%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)-1.80%
Gross profit (ttm)23.21B
EBITDA N/A
Net income avi to common (ttm)N/A
Diluted EPS (ttm)0.99
Quarterly earnings growth (yoy)-47.90%

Balance sheet

Total cash (mrq)N/A
Total cash per share (mrq)N/A
Total debt (mrq)N/A
Total debt/equity (mrq)130.48
Current ratio (mrq)0.91
Book value per share (mrq)2.41

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A